Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > THTX should have been notified that compliance is achieved

<< Previous

Bullboard Posts

Next >>

Comment by palinc2000on Aug 22, 2023 11:14am

70 Views

Post# 35599843

RE:RE:THTX should have been notified that compliance is achieved

There appears to be no delay in notification!
See example below!!!
https://www.marketscreener.com/amp/quote/stock/BIONANO-GENOMICS-INC-45064773/news/Bionano-Regains-Compliance-with-Nasdaq-Minimum-Bid-Price-Listing-Requirement-44663250/

palinc2000 wrote: The minimum bid requirement has been met for 16 consecutive days which is more than the 10 day requirement....Why is Nasdaq not issuing compliance notification?

https://www.nasdaq.com/market-activity/stocks/thtx/historical-nocp

palinc2000 wrote:
In accordance with Nasdaq Marketplace Rule 5810(c)(3)(A), the Company has a period of 180 calendar days from the date of the Notification Letter, until August 30, 2023 (the “Compliance Period”), to regain compliance with the Minimum Bid Price Requirement.

If at any time before the expiration of the Compliance Period the bid price of the Company’s common shares (the “Shares”) closes at or above US$1.00 per share for a minimum of 10 consecutive business days, Nasdaq will provide written notification that the Company has achieved compliance with the Minimum Bid Price Requirement.